Hostname: page-component-74656f9884-2dmjx Total loading time: 0 Render date: 2026-11-11T00:16:48.527Z Has data issue: false hasContentIssue false

Biological interactions and safety of graphene materials

Published online by Cambridge University Press:  23 November 2012

Ashish C. Jachak
Affiliation:
Department of Pathology and Laboratory Medicine, Brown University; Ashish_Jachak@brown.edu
Megan Creighton
Affiliation:
School of Engineering, Brown University; Megan_Creighton@brown.edu
Yang Qiu
Affiliation:
School of Engineering, Brown University; Yang_Qiu@brown.edu
Agnes B. Kane
Affiliation:
Department of Pathology and Laboratory Medicine, Brown University; Agnes_Kane@brown.edu
Robert H. Hurt
Affiliation:
School of Engineering and Institute for Molecular and Nanoscale Innovation, Brown University; Robert_Hurt@brown.edu

Abstract

As graphene technologies progress to commercialization and large-scale manufacturing, issues of material and processing safety will need to be more seriously considered. The single word “graphene” actually represents a family of related materials with large variations in number of layers, surface area, lateral dimensions, stiffness, and surface chemistry. Many of these materials have aerodynamic diameters below 5 μm and can potentially be inhaled into the human lung. Graphene materials show several unique modes of interaction with biological molecules, tissues, and cells. The limited literature suggests that graphene materials can be either benign or harmful and that the biological response varies according to a material’s physicochemical properties and biologically effective dose. The present article reviews the current literature on the graphene–biological interface with an emphasis on the mechanisms and fundamental biological responses relevant to material safety and also to potential biomedical applications

Information

Type
Research Article
Copyright
Copyright © Materials Research Society 2012
Figure 0

Figure 1. Structure and property variations in graphene-family nanomaterials. (a) Number of layers determines surface area. A plot of the Brunauer–Emmett–Teller surface area (A) and vendor-specified numbers of layers (N) for commercial few-layer-graphene (FLG) samples (squares) agrees well with the simple law A = 2630/N m2/g (curve). (b) Ranges of N and lateral dimension L in various graphene materials. Solid symbols represent commercial FLG samples, and open symbols represent graphene oxide.19–21 The bold black curve shows a 5-μm aerodynamic diameter (Dae), calculated from N and L following Reference 1, which is assumed to separate respirable and nonrespirable materials.22 Most FLGs with L > 20 μm still lie in the respirable region (Dae< 5 μm) because they are ultrathin, but might not be cleared effectively following lung deposition. One commercial sample falls into this category.

Figure 1

Figure 2. Characteristic biomolecular interactions of graphene materials. (a) Interleaflet insertion into the hydrophobic core of a lipid bilayer as predicted by coarse-grained molecular dynamics simulations.39 (b) Small-molecule adsorption driven by hydrophobic and π–π interactions and relevant to micronutrient and dye adsorption,25 as well as drug delivery using nanoscale graphene oxide (GO).20,40–42 (c) DNA intercalation in nanoscale GO in the presence of copper cations.43 (d) Preferential adsorption of single-stranded deoxyribonucleic acid (ssDNA) over double-stranded DNA (dsDNA) on GO;44,45 c-DNA is complementary DNA. The preference for ssDNA is likely related to base–graphene interactions, which are shielded in dsDNA, thus favoring desorption.44 (e) Oxidative damage to biological target molecules through bound oxygen intermediates on edge and defect sites.46

Figure 2

Figure 3. (a) Depiction of the three regions in which respirable particles can be deposited when inhaled: nasopharyngeal, tracheobronchial, and alveolar. Note that the nasopharyngeal region includes the nose, mouth, pharynx, and larynx. (b) Calculated fractional depositions of inhaled graphene-family nanomaterials (GFNs) in the nasopharyngeal, tracheobronchial, and alveolar regions of the human respiratory tract. Lateral dimensions of the GFNs range from 0.005 to 100 μm. GFNs are assumed to be 0.34 nm (one layer) thick and traveling along the polar axis. Figure modified from Sanchez et al.1

Figure 3

Figure 4. Macrophage interactions with carbon nanomaterials. (a) Partial uptake of an FLG sheet 20 layers thick and 5 μm in lateral dimension. (Scanning electron micrograph, 10,500× magnification.) (b) Complete uptake of FLG sheets, 20–30 layers thick and 550 nm in lateral dimension. (c) Attachment of macrophages to the surfaces of a single FLG sheet, 10 layers thick and 25 μm in lateral dimension. Parts (b) and (c) reproduced with permission from Reference 1. ©2012, American Chemical Society. (d) Activated macrophages in nonadherent, three-dimensional cultures aggregate around carbon nanotubes to form a granuloma. Images (b)–(d) are 0.5-μm plastic-embedded sections, toluidine blue stain, light microscopy, 1000× magnification.55,56 Part (d) reproduced with permission from Reference 14. ©2011, BioMed Central Ltd.

Figure 4

Figure 5. Routes of exposure, systemic distribution, and elimination of nanomaterials from the body following skin contact, implantation into soft tissues and bone, intravenous injection, inhalation into the respiratory tract, and ingestion. Figure modified from Obderdörster et al.66